Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
+0.11
(+0.13%)
USD |
NASDAQ |
Aug 31, 16:00
84.97
+0.02
(+0.02%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Operations (TTM) : -422.52M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -422.52M |
| March 31, 2026 | -414.17M |
| December 31, 2025 | -377.92M |
| September 30, 2025 | -349.70M |
| June 30, 2025 | -301.80M |
| March 31, 2025 | -261.57M |
| December 31, 2024 | -225.97M |
| September 30, 2024 | -199.81M |
| June 30, 2024 | -178.33M |
| March 31, 2024 | -178.44M |
| December 31, 2023 | -166.31M |
| September 30, 2023 | -163.00M |
| June 30, 2023 | -160.14M |
| March 31, 2023 | -142.38M |
| December 31, 2022 | -115.20M |
| September 30, 2022 | -102.90M |
| June 30, 2022 | -90.09M |
| Date | Value |
|---|---|
| March 31, 2022 | -82.06M |
| December 31, 2021 | -88.59M |
| September 30, 2021 | -81.63M |
| June 30, 2021 | -73.96M |
| March 31, 2021 | -69.86M |
| December 31, 2020 | -62.03M |
| September 30, 2020 | -59.54M |
| June 30, 2020 | -55.14M |
| March 31, 2020 | -51.85M |
| December 31, 2019 | -46.38M |
| September 30, 2019 | -38.94M |
| June 30, 2019 | -31.03M |
| March 31, 2019 | -22.81M |
| December 31, 2018 | -19.46M |
| September 30, 2018 | -15.96M |
| June 30, 2018 | -12.71M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Bristol Myers Squibb Co. | 12.78B |
| Corcept Therapeutics, Inc. | 109.70M |